| Application no. and date | 14874374.3 (espacenet) (Federated) (European Patent Register), 20141226 | | Patent/reg. no. and date | DK/EP 3087184, 20190703 | | Publication date | 20161102 | | Priority no. and date | US 201361921181 P, 20131227, US 201461937838 P, 20140210 | | EP pub. no. and date |
EP 3087184 20161102 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | T5972_DK | | Inventor | DUDEK, Henryk, T., 105 Overbrook Drive
Wellesley, MA 02482, US,
BROWN, Bob, D., 57 Grist Mill Road
Littleton, MA 01460, US | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , C12N 15/113 (2010.01) , C12N 9/04 (2006.01) | | Title | FREMGANGSMÅDER OG SAMMENSÆTNINGER TIL SPECIFIK INHIBERING AF GLYCOLATOXIDASE (HAO1) MED DOBBELTSTRENGET RNA | | Int. application no. | US2014072410 | | Int. publication no. | WO2015100436 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
